Skip to main content

Andes hantavirus vaccine development to accelerate within 12 months

Make a pick
user-generated· healthcare

Andes hantavirus vaccine development to accelerate within 12 months

Market overview

The recent outbreak and confirmed person-to-person transmission will likely push pharmaceutical companies and research institutions to prioritize Andes hantavirus vaccine trials. At least one clinical trial is expected to begin within a year.

healthcare prediction market

Implied probability (Yes)
62%

Source: user-generated

More healthcare markets

Browse all healthcare markets →

No one's made a Conviction call on this yet. Be the first to call it →
Loading…